FDA panel narrowly backs COVID-19 pill from Merck

By MATTHEW PERRONE (AP Health Writer)

WASHINGTON Nov. 30, 2021 10:06 p.m.

U.S. health advisers have narrowly endorsed an antiviral drug from Merck to treat COVID-19